BAC
Bank of America Corporation
BAC has the edge over SFNC overall, supported by stronger fundamentals and stronger valuation.
SFNC
Simmons First National Corporation
SFNC's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SFNC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
SFNC's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like SFNC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over SFNC in the historical PE scenario, which offers more potential upside but is not a forecast.
SFNC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $13.58 | -42% |
| Forward | 10x | $23.39 | — |
| Fair | 12x | $18.91 | -19% |
| Current | 15x | $23.39 | — |
| Expensive | 16x | $25.35 | +8.4% |
Historical ranges are pointers, not guarantees.
SFNC's PE is in its expensive range at 15x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over SFNC on the outlook, with more favorable revenue expectations.
SFNC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect SFNC's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
SFNC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus SFNC up 58%.
SFNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.27 | +41% |
| Q2 2025 | $1.27 | +6.7% |
| Q1 2025 | $1.16 | -13% |
| Q4 2024 | $1.21 | -12% |
| Q3 2024 | $1.02 | -44% |
| Q2 2024 | $1.19 | -43% |
| Q1 2024 | $1.33 | -28% |
| Q4 2023 | $1.38 | -33% |
| Q3 2023 | $1.83 | 0% |
SFNC's earnings per share have fallen from their peak: $1.61 over the past year, against $2.58 in early 2020.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
SFNC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus up 17% for SFNC.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
SFNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $248.6M | +16% |
| Q1 2026 | $241.4M | +15% |
| Q4 2025 | $249M | +19% |
| Q2 2025 | $214.2M | +8.6% |
| Q1 2025 | $209.6M | +7.4% |
| Q4 2024 | $208.5M | +17% |
| Q3 2024 | $174.8M | -11% |
| Q2 2024 | $197.2M | -5.3% |
SFNC's revenue has grown year over year for seven quarters in a row: $251M last quarter, up 17% from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with SFNC at up 4.5%.
SFNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $125.5M | +89% |
| Q1 2026 | $34M | +50% |
| Q4 2025 | $105.7M | +46% |
| Q2 2025 | $66.3M | -8.8% |
| Q1 2025 | $22.6M | -53% |
| Q4 2024 | $72.3M | -83% |
| Q3 2024 | $187.7M | +$234M |
| Q2 2024 | $72.7M | +40% |
SFNC's free cash flow was $324M over the past year, down 7.2% from the year before. Free cash flow isn't a meaningful measure for financial services companies like SFNC.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SFNC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SFNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -270K shares |
| 1 year | +15% | +18.6M shares |
| 3 years | +14% | +17.7M shares |
| 5 years | +33% | +36.2M shares |
| Available history | +47% | +46.3M shares |
SFNC has 145M diluted shares, up 15% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $75,000 |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $323,000 |
| Q3 2023 | $20M |
| Q2 2023 | $20M |
| Q1 2023 | — |
| Q4 2022 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SFNC Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SFNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.4 | Neutral |
| Stochastic | 57.2 | Neutral |
SFNC's weekly RSI is 57 (neutral) and its Stochastic is 57 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over SFNC on valuation relative to its sector.
SFNC PE vs Financial Services Sector
| Metric | SFNC | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 12% above |
| PE % | 79 | 63 | 16 pts above |
SFNC is trading at 15x earnings, a 12% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
SFNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.0 | 1.9% above |
| 20 week MA | $23.1 | 1.3% above |
| 50 week MA | $21.5 | 8.8% above |
| 100 week MA | $20.7 | 13% above |
| 200 week MA | $19.9 | 18% above |
SFNC has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
SFNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.8 | $21.1 | -21% |
| 2021 | $21.1 | $29.3 | +39% |
| 2022 | $29.3 | $21.5 | -27% |
| 2023 | $21.5 | $19.8 | -7.7% |
| 2024 | $19.8 | $22.4 | +13% |
| 2025 | $22.4 | $19.2 | -14% |
| 2026 YTD | $19.2 | $23.4 | +22% |
SFNC has the edge over BAC on returns for 2026, with the stronger performance.